Biotek-snakken — Juli 2025
-
MEDICINALINDUSTRIEN RAMT AF OVERTAGELSESFEBER...
Lægemiddelindustrien har siden årtusindskiftet oplevet næsten 33.000 fusioner og opkøb verden over med en samlet værdi på 5000 mia. dollar. For nylig aftog appetitten på fusioner og opkøb markant, men nu blusser overtagelsesfeberen op igen. (DIE PHARMABRANCHE IM ÜBERNAHMEFIEBER)
-
Kinas omkostnings- og effektivitetsfordele inden for lægemiddeludvikling er blevet anerkendt på verdens største kræftforskningskonference i USA, hvor virksomheder var på jagt efter kinesisk innovation. Næsten en tredjedel af præsentationerne på American Society of Clinical Oncologys årlige møde involverede lægemiddelkandidater fra kinesiske virksomheder. (CHINA’S DRUG PROWESS DRAWS INDUSTRY ‘SHOPPERS’: JEFFERIES)
-
Cantargia. En kanongod aftale med Otsuka. https://cantargia.com/en/press-releases/cantargia-announces-the-acquisition-of-its-can10-il1rap-immunology-program-by-otsuka-pharmaceutical
-
Godmorgen
-
JNJ siger i deres Q2 CC: And then finally, in prostate cancer. We have great momentum across our pipeline, most recently reporting, for example, an exciting bispecific T-cell engager, pasritamig, that we think has enormous potential to really transform the practice of medicine in prostate.
-
I'm super excited about our icotrokinra, the oral targeted peptide inhibitor of the IL-23 receptor, which did achieve a compelling proof of concept in ulcerative colitis. We'll be showing those data later this year at a medical meeting. We have begun gearing up now to do a broad Phase III campaign in both UC and Crohn's disease based on those compelling data
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind